136 related articles for article (PubMed ID: 11899433)
1. Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells.
Ponte-Sucre A; Heise D; Moll H
Immunology; 2001 Dec; 104(4):462-7. PubMed ID: 11899433
[TBL] [Abstract][Full Text] [Related]
2. [Leishmania major lipophosphoglycan modulates the expression of receptors involved in parasite internalization in skin Langerhans cells].
Ponte-Sucre A; Scharner A; Moll H
Acta Cient Venez; 2002; 53(3):218-24. PubMed ID: 12658871
[TBL] [Abstract][Full Text] [Related]
3. Leishmania lipophosphoglycan reduces monocyte transendothelial migration: modulation of cell adhesion molecules, intercellular junctional proteins, and chemoattractants.
Lo SK; Bovis L; Matura R; Zhu B; He S; Lum H; Turco SJ; Ho JL
J Immunol; 1998 Feb; 160(4):1857-65. PubMed ID: 9469447
[TBL] [Abstract][Full Text] [Related]
4. Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin.
Jolles S; Christensen J; Holman M; Klaus GB; Ager A
Clin Exp Immunol; 2002 Sep; 129(3):519-26. PubMed ID: 12197894
[TBL] [Abstract][Full Text] [Related]
5. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells.
Moll H; Fuchs H; Blank C; Röllinghoff M
Eur J Immunol; 1993 Jul; 23(7):1595-601. PubMed ID: 8325337
[TBL] [Abstract][Full Text] [Related]
6. Migration and maturation of Langerhans cells in skin transplants and explants.
Larsen CP; Steinman RM; Witmer-Pack M; Hankins DF; Morris PJ; Austyn JM
J Exp Med; 1990 Nov; 172(5):1483-93. PubMed ID: 2230654
[TBL] [Abstract][Full Text] [Related]
7. Production of nitric oxide by murine macrophages induced by lipophosphoglycan of Leishmania major.
Kavoosi G; Ardestani SK; Kariminia A; Tavakoli Z
Korean J Parasitol; 2006 Mar; 44(1):35-41. PubMed ID: 16514280
[TBL] [Abstract][Full Text] [Related]
8. Alpha 6 integrins are required for Langerhans cell migration from the epidermis.
Price AA; Cumberbatch M; Kimber I; Ager A
J Exp Med; 1997 Nov; 186(10):1725-35. PubMed ID: 9362532
[TBL] [Abstract][Full Text] [Related]
9. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major.
Flohé SB; Bauer C; Flohé S; Moll H
Eur J Immunol; 1998 Nov; 28(11):3800-11. PubMed ID: 9842923
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
Halliday A; Bates PA; Chance ML; Taylor MJ
Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo.
Gaiser MR; Lämmermann T; Feng X; Igyarto BZ; Kaplan DH; Tessarollo L; Germain RN; Udey MC
Proc Natl Acad Sci U S A; 2012 Apr; 109(15):E889-97. PubMed ID: 22411813
[TBL] [Abstract][Full Text] [Related]
12. Influence of ageing on Langerhans cell migration in mice: identification of a putative deficiency of epidermal interleukin-1beta.
Cumberbatch M; Dearman RJ; Kimber I
Immunology; 2002 Apr; 105(4):466-77. PubMed ID: 11985667
[TBL] [Abstract][Full Text] [Related]
13. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration.
Cumberbatch M; Kimber I
Immunology; 1992 Feb; 75(2):257-63. PubMed ID: 1551688
[TBL] [Abstract][Full Text] [Related]
14. Characterization of lipophosphoglycan from a ricin-resistant mutant of Leishmania major.
Opat A; Ng K; Currie G; Handman E; Bacic A
Glycobiology; 1996 Jun; 6(4):387-97. PubMed ID: 8842702
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, stability, and subcellular distribution of major histocompatibility complex class II molecules in Langerhans cells infected with Leishmania major.
Flohé S; Lang T; Moll H
Infect Immun; 1997 Aug; 65(8):3444-50. PubMed ID: 9234810
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of epidermal Langerhans cell function by low dose ultraviolet B radiation. Ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells.
Tang A; Udey MC
J Immunol; 1991 May; 146(10):3347-55. PubMed ID: 1673983
[TBL] [Abstract][Full Text] [Related]
17. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
Ritter U; Meissner A; Scheidig C; Körner H
Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
[TBL] [Abstract][Full Text] [Related]
18. Accessory and adhesion molecules expressed on murine epidermal Langerhans cells and the modulation by cytokines.
Nakamura K; Tamaki K
J Dermatol Sci; 1998 May; 20(1):14-20. PubMed ID: 10342744
[TBL] [Abstract][Full Text] [Related]
19. Induction of regulatory dendritic cells by topical application of NF-kappaB decoy oligodeoxynucleotides.
Isomura I; Shintani Y; Yasuda Y; Tsujimura K; Morita A
Immunol Lett; 2008 Aug; 119(1-2):49-56. PubMed ID: 18547648
[TBL] [Abstract][Full Text] [Related]
20. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
